Juan Carlos Yébenes

Dr. Juan Carlos Yébenes

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
ILIsabel Lorenzo
Isabel Lorenzo
MSMateu Serra-Prat
Mateu Serra-Prat
JYJuan Carlos Yébenes
Juan Carlos Yébenes
Water, the main component of the body, is distributed in the extracellular and intracellular compartments. Water exchange between these compartments is mainly governed by osmotic pressure. Extracellular water osmolarity must remain within very narrow limits to be compatible with life. Older adults lose the thirst sensation and the ability to concentrate urine, and this favours increased extracellular osmolarity (hyperosmotic stress). This situation, in turn, leads to cell dehydration, which has severe consequences for the intracellular protein structure and function and, ultimately, results in cell damage. Moreover, the fact that water determines cell volume may act as a metabolic signal, with cell swelling acting as an anabolic signal and cell shrinkage acting as a catabolic signal. Ageing also leads to a progressive loss in muscle mass and strength. Muscle strength is the main determinant of functional capacity, and, in elderly people, depends more on muscle quality than on muscle quantity (or muscle mass). Intracellular water content in lean mass has been related to muscle strength, functional capacity, and frailty risk, and has been proposed as an indicator of muscle quality and cell hydration. This review aims to assess the role of hyperosmotic stress and cell dehydration on muscle function and frailty.

22 April 2008 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
RFRafael Fernandez
Rafael Fernandez
XTXavier Trenchs
Xavier Trenchs
JKJordi Klamburg
Jordi Klamburg
JCJon Castedo
Jon Castedo
JSJose Manuel Serrano
Jose Manuel Serrano
MLMaria Jesus Lopez
Maria Jesus Lopez

1 February 2016 in Journal of Infection
Verified
Journal Article
Open access
ALEJANDRO HUGO RODRIGUEZ OVIEDOALEJANDRO HUGO RODRIGUEZ OVIEDO
ALEJANDRO HUGO RODRIGUEZ OVIEDO
FAFrancesc Xavier Avilés-Jurado
Francesc Xavier Avilés-Jurado
EDEmili Diaz
Emili Diaz
PSPhilipp Schuetz
Philipp Schuetz
STSandra I. Trefler
Sandra I. Trefler
ARAntoli Ribas
Antoli Ribas
To define which variables upon ICU admission could be related to the presence of coinfection using CHAID (Chi-squared Automatic Interaction Detection) analysis. A secondary analysis from a prospective, multicentre, observational study (2009-2014) in ICU patients with confirmed A(H1N1)pdm09 infection. We assessed the potential of biomarkers and clinical variables upon admission to the ICU for coinfection diagnosis using CHAID analysis. Performance of cut-off points obtained was determined on the basis of the binominal distributions of the true (+) and true (-) results. Of the 972 patients included, 196 (20.3%) had coinfection. Procalcitonin (PCT; ng/mL 2.4 vs. 0.5, p < 0.001), but not C-reactive protein (CRP; mg/dL 25 vs. 38.5; p = 0.62) was higher in patients with coinfection. In CHAID analyses, PCT was the most important variable for coinfection. PCT <0.29 ng/mL showed high sensitivity (Se = 88.2%), low Sp (33.2%) and high negative predictive value (NPV = 91.9%). The absence of shock improved classification capacity. Thus, for PCT <0.29 ng/mL, the Se was 84%, the Sp 43% and an NPV of 94% with a post-test probability of coinfection of only 6%. PCT has a high negative predictive value (94%) and lower PCT levels seems to be a good tool for excluding coinfection, particularly for patients without shock.

31 August 2016 in Pharmacology
Verified
Journal Article
Open access
PDF file
LCLluís Campins
Lluís Campins
MCMarcella Camps
Marcella Camps
ARAriadna Riera
Ariadna Riera
EPEulogio Pleguezuelos
Eulogio Pleguezuelos
JYJuan Carlos Yébenes
Juan Carlos Yébenes
MSMateu Serra-Prat
Mateu Serra-Prat
Sarcopenia is a geriatric syndrome characterized by progressive and generalized loss of skeletal muscle mass and function. Reported prevalence of this geriatric syndrome, differs depending on the definition, the population and the method used to identify sarcopenia. The causes of sarcopenia are multifactorial, and can include genetic influence, immobility or disuse, endocrine factors, inflammation and nutritional deficiencies. These disorders involve an imbalance between anabolic and catabolic pathways that rules muscle mass. Many drugs taken regularly for common conditions may interact with some mechanisms that can alter the balance between protein synthesis and degradation. This may lead to a harmful or a beneficial effect on muscle mass and strength. Widely prescribed drugs could play an important role during the time of onset and development of sarcopenia. In this paper, we reviewed the current understanding of how can drugs contribute positively or negatively on sarcopenia and muscle wasting. We decided to focus this review on oral common drugs, which are usually prescribed in older adults, leaving aside other drugs as hormone therapy.

1 January 2017 in Annals of Intensive Care
Verified
Journal Article
Open access
PDF file
JYJuan Carlos Yébenes
Juan Carlos Yébenes
Juan Carlos RodríguezJuan Carlos Rodríguez
Juan Carlos Rodríguez
RFRicard Ferrer
Ricard Ferrer
MCMontserrat Clèries
Montserrat Clèries
ABAnna Bosch
Anna Bosch
Antonio ArtigasAntonio Artigas
Antonio Artigas
Up-to-date identification of local trends in sepsis incidence and outcomes is of considerable public health importance. The aim of our study was to estimate annual incidence rates and in-hospital mortality trends for hospitalized patients with sepsis in a European setting, while avoiding selection bias in relation to different complexity hospitals. A large retrospective analysis of a 5-year period (2008–2012) was conducted of hospital discharge records obtained from the Catalan Health System (CatSalut) Minimum Basic Data Set for Acute-Care Hospitals (a mandatory population-based register of admissions to all public and private acute-care hospitals in Catalonia). Patients hospitalized with sepsis were detected on the basis of ICD-9-CM codes used to identify acute organ dysfunction and infectious processes. Of 4,761,726 discharges from all acute-care hospitals in Catalonia, 82,300 cases (1.72%) had sepsis diagnoses. Annual incidence was 212.7 per 100,000 inhabitants/year, rising from 167.2 in 2008 to 261.8 in 2012. Length of hospital stay fell from 18.4 to 15.3 days (p < .00001), representing a relative reduction of 17%. Hospital mortality fell from 23.7 to 19.7% (p < .0001), representing a relative reduction of 16.9%. These differences were confirmed in the multivariate analysis (adjusted for age group, sex, comorbidities, ICU admission, emergency admission, organ dysfunction, number of organ failures, sepsis source and bacteraemia). Sepsis incidence has risen in recent years, whereas mortality has fallen. Our findings confirm reports for other parts of the world, in the context of scarce administrative data on sepsis in Europe.

1 August 2004 in American Journal of Infection Control
Verified
Journal Article
Closed access
JYJuan Carlos Yébenes
Juan Carlos Yébenes
LVLoreto Vidaur
Loreto Vidaur
MSMateu Serra-Prat
Mateu Serra-Prat
JSJosep M Sirvent
Josep M Sirvent
JBJordi Batlle
Jordi Batlle
MPMercedes Palomar
Mercedes Palomar